Common Stock, Shares, Outstanding of CRESCENT BIOPHARMA, INC. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CRESCENT BIOPHARMA, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • CRESCENT BIOPHARMA, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 27,556,767, a 2605% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

CRESCENT BIOPHARMA, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 27,556,767 +26,538,163 +2605% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 13,892,516 -50,591,442 -78% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 13,892,562 -50,591,396 -78% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 64,532,091 +81,256 +0.13% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 1,018,604 -63,375,140 -98% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 64,483,958 +115,115 +0.18% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 64,483,958 +170,625 +0.26% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 64,450,835 +205,611 +0.32% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 64,393,744 +10,015,946 +18% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 64,368,843 +11,944,899 +23% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 64,313,333 +11,889,389 +23% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 64,245,224 +12,506,330 +24% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 54,377,798 +2,063,904 +3.9% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 52,423,944 +685,050 +1.3% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 52,423,944 +884,934 +1.7% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 51,738,894 +199,884 +0.39% 31 Mar 2022 10-Q 28 Apr 2022 2022 Q1
Q4 2021 52,313,894 +3,296,272 +6.7% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 51,738,894 +3,910,063 +8.2% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 51,539,010 +4,824,312 +10% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 51,539,010 +7,956,031 +18% 31 Mar 2021 10-Q 03 May 2021 2021 Q1
Q4 2020 49,017,622 +5,550,689 +13% 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q3 2020 47,828,831 +4,468,882 +10% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 46,714,698 +3,521,508 +8.2% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 43,582,979 +402,810 +0.93% 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 43,466,933 +306,182 +0.71% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 43,359,949 +222,722 +0.52% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 43,193,190 +137,766 +0.32% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 43,180,169 +690,059 +1.6% 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 43,160,751 +8,800,952 +26% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 43,137,227 +10,399,428 +32% 30 Sep 2018 10-Q 02 Nov 2018 2018 Q3
Q2 2018 43,055,424 +10,339,067 +32% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 42,490,110 +18,634,176 +78% 31 Mar 2018 10-Q 03 May 2018 2018 Q1
Q4 2017 34,359,799 +11,109,776 +48% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 32,737,799 +9,674,369 +42% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 32,716,357 +9,685,947 +42% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 23,855,934 +4,575,244 +24% 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 23,250,023 +4,199,819 +22% 31 Dec 2016 10-K 06 Mar 2018 2017 FY
Q3 2016 23,063,430 +4,026,297 +21% 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 23,030,410 +4,011,277 +21% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 19,280,690 +273,557 +1.4% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 19,050,204 +110,366 +0.58% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 19,037,133 +143,291 +0.76% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 19,019,133 +125,669 +0.66% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 19,007,133 +225,181 +1.2% 31 Mar 2015 10-Q 05 May 2015 2015 Q1
Q4 2014 18,939,838 +17,513,245 +1228% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 18,893,842 30 Sep 2014 10-Q 31 Oct 2014 2014 Q3
Q2 2014 18,893,464 30 Jun 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 18,781,952 31 Mar 2014 10-Q 09 May 2014 2014 Q1
Q4 2013 1,426,593 31 Dec 2013 10-K 16 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.